Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
30 /100
MEDIUM RISK
Score updated Oct 13, 2026

MNPR — Monopar Therapeutics Inc. Dilution Risk Tracker

Track MNPR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MNPR — Get alerts when the score changes →

As of October 13, 2026, Monopar Therapeutics Inc. (MNPR) has a DilutionWatch DilutionScore of 30/100, rated MEDIUM dilution risk. Monopar Therapeutics Inc. has a market capitalization of $529.99M, 6.71M shares outstanding, 82 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
0
📊 Float Risk
40
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for MNPR.
🔔 Track MNPR — Get forecast alerts →

Market Data

Market Cap$529.99M
Shares Outstanding6.71M
Float4.13M
Cash$52.76M
Debt$230.4K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore30/100DilutionWatch score record
Shares Outstanding6.71MVerified float table or market cache
Public Float4.13MVerified float table or market cache
Market Cap$529.99MMarket data cache
Cash Runway48.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 5.

Recent SEC source mix: 3 1, 4 4.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 38.8% shares (2026Q1 vs prior)
82 institutional holders · 8.00M shares
#1 JANUS HENDERSON GROUP PLC 2.63M shares
#2 RA CAPITAL MANAGEMENT, L.P. 667.2K shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 436.9K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.09M
Days to Cover6.0
% of Float26.3%
FINRA data as of Sep 30, 2026

Recent SEC Activity

4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-03-04
3 FORM3 2026-03-04
4 INSIDER TRANSACTION 2026-01-30
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual MNPR Dilution Snapshot

Monopar Therapeutics Inc. (MNPR) has a DilutionScore of 30/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

MNPR's DilutionScore is currently 30/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 33/100 (Medium risk).

Period Score Risk Level Duration
Sep 19 – Oct 13, 202630/100MEDIUM25 days
Aug 24 – Sep 18, 202633/100MEDIUM26 days
Jul 16 – Aug 23, 202638/100MEDIUM38 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

MNPR shares outstanding have increased 0.2% from 6.68M (Mar 2026) to 6.70M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 20266.70M4.13M▼ 7.72%
May 16, 20266.70M4.48M▲ 1.79%
Apr 11, 20266.69M4.40M▲ 0.07%
Apr 08, 20266.69M4.39M▼ 0.15%
Mar 28, 20266.68M4.40M▲ 0.14%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track MNPR Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment MNPR files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking MNPR — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for MNPR
MNPR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.